District court upholds AstraZeneca’s migraine drug patents

31-03-2017

District court upholds AstraZeneca’s migraine drug patents

Fotonen / iStockphoto.com

The US District Court for the District of Delaware has upheld AstraZenca’s patents protecting Zomig (zolmitriptan) in a dispute with generic manufacturer Lannett.


migraine, patent, Zomig, nasal spray, Lannett, AstraZeneca, Impax

LSIPR